Biofil Chemicals & Pharmaceuticals vs Peers
- Market cap
- ₹49.7 crore
- P/E
- 102.7
- P/B
- 2.30
- ROE
- 13.8%
- Dividend yield
- 1.20%
Biofil Chemicals & Pharmaceuticals ranks 71st by market capitalisation among 71 Pharmaceuticals companies tracked by ATS. Its largest peers are Sun Pharmaceutical Industries, Divi's Laboratories and Torrent Pharmaceuticals. Its P/E of 102.7 compares with a peer median of 33.6.
Biofil Chemicals & Pharmaceuticals vs Pharmaceuticals peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,773.60 | -1.69% | 4,25,546 | 35.2 | 5.09 | 14.7% | +12.5% |
| Divi's Laboratories | 9,586.00 | +0.38% | 2,54,478 | 87.0 | 15.18 | 16.2% | +12.5% |
| Torrent Pharmaceuticals | 4,693.90 | -1.64% | 1,58,863 | 72.8 | 18.94 | 27.1% | +12.5% |
| Zydus Lifesciences | 1,151.30 | -0.71% | 1,15,848 | 25.7 | 4.27 | 19.7% | +12.5% |
| Laurus Labs | 2,052.90 | +0.14% | 1,10,827 | 101.4 | 20.91 | 18.2% | +12.5% |
| Cipla | 1,333.00 | -0.54% | 1,07,677 | 32.0 | 3.13 | 11.8% | +12.5% |
| Mankind Pharma | 2,496.00 | -0.16% | 1,03,042 | 50.4 | 6.32 | 12.5% | +12.5% |
| Dr. Reddy's Laboratories | 1,194.90 | -1.08% | 99,533 | 30.1 | 2.60 | 12.1% | +12.5% |
| Aurobindo Pharma | 1,677.90 | -0.88% | 97,453 | 26.3 | 2.57 | 9.9% | +12.5% |
| Lupin | 2,006.70 | -1.11% | 91,742 | 16.6 | 4.09 | 26.9% | +12.5% |
| Biofil Chemicals & Pharmaceuticals | 30.54 | +1.43% | 49.7 | 102.7 | 2.30 | 13.8% | — |
Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.
Biofil Chemicals & Pharmaceuticals peer comparison — frequently asked questions
Who are Biofil Chemicals & Pharmaceuticals' competitors?
Biofil Chemicals & Pharmaceuticals' listed peers in Pharmaceuticals include Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, Laurus Labs and Cipla, ranked here by market capitalisation.
How does Biofil Chemicals & Pharmaceuticals' P/E compare with its peers?
Biofil Chemicals & Pharmaceuticals trades at a P/E of 102.7, against a median of 33.6 across the 10 Pharmaceuticals peers shown.
Which is the largest company among Biofil Chemicals & Pharmaceuticals' peers?
By market capitalisation, the largest company in the group is Sun Pharmaceutical Industries at ₹4.26 lakh crore, against ₹49.7 crore for Biofil Chemicals & Pharmaceuticals.
Same Data For Peers
Trade Biofil Chemicals & Pharmaceuticals With ATS
Track BIOFILCHEM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.